Status:
COMPLETED
Potassium in Haemodialysis Fluids and Haemodynamics
Lead Sponsor:
Ospedale Regionale di Locarno
Collaborating Sponsors:
Fondazione Ettore Balli Locarno
Conditions:
Haemodialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In a study published in 1995 in the American Journal of Kidney Diseases, Dolson et al demonstrated that a rapid decrease of serum potassium concentrations during haemodialysis would produce a signific...
Detailed Description
INTRODUCTION: Potassium is the most abundant cation in the body (35-40 mmol/kg in haemodialysis patients \[1\]), although only 2% of the pool is located extracellularly \[2\]. Whereas, on a short-ter...
Eligibility Criteria
Inclusion
- chronic haemodialysis patients
- dialysed 3 to 4 hours three times a week
- clinically stable and without intercurrent illnesses
Exclusion
- intercurrent illnesses
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01224314
Start Date
September 1 2007
End Date
December 1 2007
Last Update
October 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Regionale di Locarno
Locarno, Canton Ticino, Switzerland, 6600